Clinical evaluation of meloxicam, roficoxib and their combination with serratiopeptid ase during long term administration in dogs

The side effects caused by Meloxicam, Rofecoxib and their combination with Serratiopeptidase when given I/M for a long time as anti inflammatory in 30 dogs were studied. There was no significant change in the clinical parameters like rectal temperature, pulse and respiratory rates in all treated groups when compared with the control group. It was observed that in healthy dogs meloxicam appears to be safe with regard to adverse effects on the gastro intestinal tract.